Paediatric Medicines: Formulation Considerations

Journal Title: Archives of Pharmacy and Pharmaceutical Sciences - Year 2017, Vol 1, Issue 1

Abstract

The use of unlicensed and off-label medicines in children is widespread and has raised an increasing concern over the last years. The majority of medicines taken by children are extemporaneously compounded by pharmacist, and there is a lack of information regarding bioavailability, suitability and stability. These formulations must be prepared from pure active substance and not from commercially available dosage forms. The development of paediatric formulations, particularly those suitable for very young children, can be a challenge to pharmacists. There is limited knowledge available about the acceptability of different dosage forms, administration volume, dosage form size, taste, safety of formulation excipients regarding to age and development status. The selection of formulation and route of administration depends on the disease being treated and the clinical condition. European Guidelines and reflection papers recommend that pharmaceutical development should consider some parameters like capability, acute or long-term illness, caregiver convenience, disability, culture differences and formulations more attractive to children must be explored.

Authors and Affiliations

Fátima Roque

Keywords

Related Articles

Kinematics and Electromyographic Analysis of Gait with Different Footwear

Kinematic analysis and surface electromyography are tools being used as important methods to evaluate the human gait and to analyze different types of footwear aiming modifications and adaptations to the human locomotor...

Preparation, solid state characterization and evaluation of ketoprofen-glucosamine HCl solid dispersions

In this investigation, solid dispersions were prepared and characterized to improve the solubility and dissolution of poorly water soluble drug Ketoprofen, using glucosamine HCl as a carrier. For the improvement of the s...

Biologic therapy-Related demyelinating peripheral neuropathy in a child with Juvenile Idiopathic Arthritis

Demyelinating peripheral neuropathy has been described in association with tumor necrosis factor (TNF) inhibitors. It is rarely developed after treatment discontinuation. We present the case of a child with juvenile idio...

Preclinical studies for a cationic liposome formulation containing Il-2 Intended for the treatment of Human Tumors

Human cervical cancer tumours expressing the IL-2 receptor (IL-2R) were induced in the peritoneal cavity of nude mice. The tumours were significantly reduced by the i.p. administration of either free IL-2 or liposomes co...

Some Aspects of medicine distribution in Sudan

The strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade, and has had a positive result on government deficit. The investment law approved recently has good statements and...

Download PDF file
  • EP ID EP560269
  • DOI 10.29328/journal.hps.1001004
  • Views 55
  • Downloads 0

How To Cite

Fátima Roque (2017). Paediatric Medicines: Formulation Considerations. Archives of Pharmacy and Pharmaceutical Sciences, 1(1), 24-27. https://europub.co.uk/articles/-A-560269